Rappel de Zenith Alpha Thoracic Endovascular Graft

Selon Department of Health, Therapeutic Goods Administration, ce/cet/cette rappel concerne un dispositif en/au/aux/à Australia qui a été fabriqué par William A Cook Australia Pty Ltd.

Qu'est-ce que c'est?

Une correction ou un retrait opéré par un fabricant afin de répondre à un problème causé par un dispositif médical. Les rappels surviennent lorsqu'un dispositif médical est défectueux, lorsqu'il pourrait poser un risque pour la santé, ou les deux à la fois.

En savoir plus sur les données ici
  • Type d'événement
    Recall
  • ID de l'événement
    RC-2017-RN-00824-1
  • Classe de risque de l'événement
    Class I
  • Date de mise en oeuvre de l'événement
    2017-06-28
  • Pays de l'événement
  • Source de l'événement
    DHTGA
  • URL de la source de l'événement
  • Notes / Alertes
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • Notes supplémentaires dans les données
  • Cause
    Cook medical previously advised customers in march 2017 (rc-2017-rn-00419-1) about an update to the instructions for use (ifu) for the zenith alpha thoracic endovascular graft.Since then, cook medical has received additional complaints for the same issue. although the complaints were from patients treated prior to the march notification, there is now an additional correction of the (ifu) and the removal of specific sizes from the market.The correction to the ifu removes the indication for use in blunt thoracic aortic injury (btai), and a warning has been added to describe the thrombus risk that has been observed when the device is used to treat btai. patients already treated with this product for the btai indication should be followed up according to the current ifu, with considerations outlined in cook medical’s correspondence in march 2017.Potential adverse events that may occur if these devices were used for btai include death, paraplegia, and/or surgical intervention.
  • Action
    Cook Medical is requesting that Customers: 1. Share this notice with others in their organisation who either use this device or follow patients treated with this device. 2. Follow the IFU corrections as provided. 3. Examine inventory and immediately quarantine affected products. 4. Complete and return the required Acknowledgement and Receipt Form, in addition to any affected recalled products to Cook Medical. Return Goods Authorisation Number: QCR-75 Cook Medical 61 Brandl Street Eight Mile Plains QLD 4113 5. Maintain a copy of this notice for their records. Upon availability of the corrected IFU, a Cook Medical Sales Representative will personally follow-up and provide corrected IFUs for inventory.

Device

  • Modèle / numéro de série
    Zenith Alpha Thoracic Endovascular GraftCatalogue Numbers: ZTA-D-/-ZTA-DE-/-ZTA-P-/-ZTA-PT-/- Multiple Catalogue Identifier and Global Product NumbersAll LotsARTG Numbers: 222505, 222526, 222533, 222525
  • Classification du dispositif
  • Manufacturer

Manufacturer